Knowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.
Bill Barr
Advertisement
Articles by Bill Barr
Bill Barr outlines the systematic application of three criteria to guide discounting decisions.
Advertisement
Latest Updated Articles
Payer Contracting: Three Criteria for SuccessPublished: April 18th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
Evolution of Biotech CFOs
5
